Environmental Imaginaries and the Environmental Sciences of Antimicrobial Resistance

The environmental dimension of antimicrobial resistance has expanded the scope and scale of policy concern and research interest in antimicrobial resistance to include not just clinical and agricultural settings but a wide variety of environmental spaces and places. This article examines the ways in which environmental scientists researching the environmental dimension of antimicrobial resistance produce culturally specific forms of environmental imaginaries as a means of stabilising complex, uneven and open-ended environmental, human and microbial relations. These imaginaries work to structure the gaze of scientific enquiry towards particular places, objects and scales, and justify particular decisions and practices over others. Drawing on the imaginaries literature from Science and Technology Studies and Cultural Geography, our analysis examines the spatial and temporal dimensions of environmental imaginaries. In doing so, we identify four imaginaries, the environmental hotspot, the pristine environment, the fluid environment and the environmental reservoir. These distinct but interconnected imaginaries produce a constellation of ideas and assumptions that shape scientific practices, the ways and places in which the environmental dimension of antimicrobial resistance becomes known, and the types of interventions and actions that are made apprehensible as a result. In opening these imaginaries to interrogation at this relatively formative stage, we aim to identify ways in which social science contributions can complement and enhance the ways in which the figure of ‘the environment’ is brought to bear on responses to antimicrobial resistance.

“Mind the Gaps”

Background

There is growing global awareness of the pivotal role environmental factors, including pharmaceutical manufacturing waste, play in the development and spread of antimicrobial resistance (AMR). India bears one of the highest burdens of AMR globally and possesses a substantial manufacturing sector, but limited insight is available on how to practically mitigate environmental AMR-related risk in this context.

Objective

To understand the barriers and opportunities in managing manufacturing waste for addressing AMR in the environment from the perspectives of stakeholders in India.

Methods

We conducted semi-structured interviews with a range of stakeholders from government, industry, and civil society following a stakeholder mapping and analysis process within the Indian context. We also undertook a series of stakeholder events to inform the study.

Results

Our findings indicate that 1) Policy action is fragmentary and there are economic and capacity gaps that have implications for industry behaviours; 2) A One Health approach to addressing AMR in the environment requires leadership and that means AMR prevention needs to be institutionalised within government for them to steer, facilitate and coordinate; and 3) There is a need to enhance knowledge amongst policymakers in India about AMR in the environment, and robust ‘evidence’ is required to foster policy change.

Conclusions

The study underscores the need for a multifaceted strategy to address the contribution of pharmaceutical manufacturing waste to AMR in the environment in India. Greater prioritisation of AMR, stakeholder collaboration, and capacity building are essential to overcoming the challenges identified.

Rethinking the Words Hotspot Reservoir and Pristine in the Environmental Dimensions of Antimicrobial Resistance

We assess three words commonly used to represent the environmental dimensions of antimicrobial resistance (AMR) – ‘hotspot’, ‘reservoir’ and ‘pristine’ – through two questions: how are these terms used in published research; and how do these terms shape research being conducted? We advocate for the community to reflect on and improve its use of language, and suggest four potentially more productive and precise terms for AMR hazard: prevalence; transmission; evolution and connectivity.

Development Histories, AMR Futures, and the Biosociality of a ‘Hotspot’

Paul Rabinow identified ‘practices of life’ as a potent site of twenty-first-century knowledge and power, arguing that instruments of genomic characterisation will reshape contemporary social relations, thus establishing a new politics of the molecular. Rabinow named this new epoch biosociality. In Antimicrobial Resistance (AMR) surveillance terms, gene sequencing technologies and bioinformatics programmes are used to determine resistance profiles of humans, nonhuman animals, and the environments they are embedded within. A regime of global governance has grown around the statistical analysis of the data produced by these new technologies, in which geographic locations displaying certain resistance profiles are designated as ‘hotspots’ of resistance emergence, justifying intervention in the behaviours of the populations inhabiting them.

Producers of statistical data have identified a correlation between AMR gene prevalence and abundance and national development status. They call for more research into the socioeconomic and political capacities of nations to respond to the AMR challenge. This article responds to that call by examining AMR in the context of global development. It explores the processes by which global development regimes have created and perpetuated environments conducive to the production of AMR hotspots in low-income countries. Focusing on two case studies – Bangladesh’s export aquaculture sector and rural development in the West African Republic of Benin – I speculate how histories of postcolonial development potentially configure AMR hotspots. Drawing upon Hannah Landecker’s ‘biology of history’ concept, I argue that the historical development regimes, and the ideologies that underpinned them, have contributed to AMR futures. The article concludes by cautioning that unless combined with insights from qualitative research, advances in biotechnologies – and the knowledge they produce – risk turning the molecular into the latest iteration of North-South domination, perpetuating uneven power relationships and racialised stereotypes by designating certain populations as risky producers of AMR.

Mapping Antibiotic Pollution and Tracking Drivers of Environmental AMR in a North Indian Pharmaceutical Hub

Introduction: Antibiotic residues in the environment contribute to the escalating threat of antimicrobial resistance (AMR), posing significant risks to public health and ecological systems. Understanding how antibiotics enter the environment during their lifecycle is crucial for developing effective mitigation strategies. This paper maps antibiotic pollution pathways in Baddi, Himachal Pradesh, highlighting the potential environmental and human health impacts of antimicrobial production, consumption, and disposal.

Methods: A mixed-methods approach was used, combining qualitative interviews with stakeholders and community members, and quantitative analysis of sales data. Interviews with manufacturers, healthcare providers, and waste management officials provided insights into practices and perceptions related to antibiotic use and disposal. Sales data of four locally manufactured or packaged antibiotics during the COVID-19 pandemic were analyzed to trace their journey through the supply chain and identify potential points of environmental entry for antibiotic residues.

Results: The study identified several critical points in the antibiotic supply chain where residues could enter the environment, including manufacturing discharge, disposal practices by consumers, and inadequate waste management systems. The analysis revealed an increase in antibiotic consumption during the COVID-19 pandemic, exacerbating the potential environmental burden. Key areas requiring oversight and management were highlighted, such as the need for better waste treatment facilities and stricter regulatory controls.

Discussion: This research emphasizes the urgent need for a coordinated response at both the state and national levels to enhance environmental monitoring, improve waste management practices, and strengthen regulatory frameworks in India. Addressing these issues is essential to mitigate the growing threat of AMR and protect both environmental and human health. The findings advocate for comprehensive strategies involving multiple stakeholders to ensure sustainable management of antibiotics throughout their lifecycle.

Shit Voyeurism, Anti-Blackness, and the Spherical

This piece interrogates anti-Black racism and coloniality in global health reporting on antibiotic use in Africa. I focus on New York Times discourse, imagery, and films, reading these intertextually with wider political and public health rhetoric. In critically attending to mediated imaginaries of Nairobi, Kenya as “unhygienic,” I demonstrate how this figuration comes to index local pharmaceutical practices that appear “non-Scientific.” The situated knowledge informing such practices is disregarded or, worse, presented as a threat to be targeted and eliminated. Such biomedical transgressions are indexed in the NYT by racialized references to waste, dirt, and excrement, turning the (structurally white) reader-viewer into what I call a shit voyeur. Building on Sylvia Wynter’s conceptualization of Man, I argue that Man-the-shit voyeur disregards his own culpability in rising antimicrobial resistance, locating health risks instead in the contaminating nature of Others. This racialized grammar is further subtended by the logic of the spherical—the illusion that the world-as-sphere is a totality that Man can perceive with a unidirectional gaze. Global health reporting that is racialized via the logics of the spherical and shit voyeurism not only fails to accurately represent medical concerns in Africa but also perpetuates biomedical hegemony and/as global white supremacy.

States of Resistance

Drawing on institutional historical records, interviews and student theses, this article charts the intersection of hospital acquired illness, the emergence of antimicrobial resistance (AMR), environments of armed conflict, and larger questions of social governance in the specific case of the American University of Beirut Medical Center (AUBMC) in Lebanon. Taking a methodological cue from approaches in contemporary scientific work that understand non-clinical settings as a fundamental aspect of the history and development of AMR, we treat the hospital as not just nested in a set of social and environmental contexts, but frequently housing within itself elements of social and environmental history. AMR in Lebanon differs in important ways from the settings in which global protocols for infection control or rubrics for risk factor identification for resistant nosocomial outbreaks were originally generated. While such differences are all too often depicted as failures of low and middle-income countries (LMIC) to maintain universal standards, the historical question before us is quite the reverse: how have the putatively universal rubrics of AMR and hospital infection control failed to take account of social and environmental conditions that clearly matter deeply in the evolution and spread of resistance? Focusing on conditions of war as an organized chaos in which social, environmental and clinical factors shift dramatically, on the social and political topography of patient transfer, and on a missing “meso” level of AMR surveillance between the local and global settings, we show how a multisectoral One Health approach to AMR could be enriched by an answering multisectoral methodology in history, particularly one that unsettles a canonical focus on the story of AMR in the Euro-American context.

The invisible city

More-than-human, multispecies and animal geographic accounts of the city have tended to focus on large, charismatic and wild organisms, to the detriment of spatially invisible other-than-humans that are central to urban reproduction. At the same time, urban microbial geographies have foregrounded embodied interactions between humans and microorganisms, whether they are symbiotic or pathogenic, often marginalising the material contributions of extracorporeal microbiomes to the urban fabric. Building from these two blindspots, this article focuses on microbial ecologies that live constitutively outside of (other-than-)human bodies and which are intimately caught up in the metabolic intensities and infrastructural environments of the urban realm. There are two key aims: (1) to explore different forms of urban microbial ecologies and (2) to examine their relationships with urban infrastructures and reproduction. My disciplinary lenses are animal geography, microbe studies and urban ecology and my case studies are focused on urban water metabolism. Thus, based on empirical fieldwork on the urban River Lea in East London and supplemented by scientific literature and technical documents, I analyse three urban microbial ecologies that correspond to the urban realms’ ‘extended microbiomes’: those involved in slow sand filtration for the treatment of drinkable water, those involved in sewage treatment via the activated sludge process and those emerging and evolving in disused urban canal infrastructure. These processes spatially manage microbial growth and modulate the distribution of different forms of microbial agency with important effects for the smooth functioning of urban water metabolism. I suggest these ecologies correspond to the ‘spaces’ of microbes in the city, and characterise a mundane system of repetition and regulation. However, microbes continue to assert their agency within the spaces of urban water metabolism, create their own places and worlds and highlight a more-than-human contingency and indeterminacy at the heart of urban reproduction.

Microbes and Marginalisation

Reducing human-microbial encounters through improved infection prevention and control (IPC) is widely acknowledged to be critical for reducing the emergence, transmission and burden of antimicrobial resistance (AMR). However, despite its centrality in the Global Action Plan (GAP) on AMR and adoption as a goal in National Action Plans around the world, there has been limited progress on reducing the incidence of antimicrobial resistant infections globally. In this paper, we argue that closer attention to different faces of AMR could propel progress in this area, with a focus on bedridden people situated in liminal spaces in the Thai health system and suburban economy. Our ethnographic fieldwork followed the cases of 16 bedridden people through the eyes of their carers and medical staff. We ‘descended into the ordinary’ to encounter individuals living – and dying – in the shadows of the labour-intensive suburbs of Bangkok. Here, AMR and IPC protocols are operationalised in the context of competing priorities and pragmatic decision-making. Focussing on three ethnographic vignettes, we use the analytic frames of precarity and care to consider how particular (bedridden) bodies are differentially exposed to AMR infections in the context of economic, social, and political arrangements that structure embodied vulnerabilities and forms and foci of care. Whilst the political work of calculating the burden of AMR may be oriented around galvanising support through a sense of magnitude and generalised risk, this research serves as a reminder that the faces of AMR include those who disproportionately shoulder the global burden of AMR, making it at once exceptional and ordinary.

Antibiotics in pig meat production

For people interested in high-quality food, Italy has long been acknowledged for its production of Parma ham, salami and similar pig meat-based products. For researchers in the field of antibiotic resistance, they are known as products of a highly antibiotic-dependent production system. Italy has one of the highest consumptions of antibiotics by animals in the EU, estimated to be 244 mg/PCU. By contrast, Sweden has the lowest consumption of antibiotics by animals in the EU, estimated to be 12.5 mg/PCU. Thus, the Italian level is about 20 times higher than the Swedish one. The aim of this paper is to pinpoint the role of antibiotics in the Swedish and Italian production systems. What are the underlying forces and the key features of the Swedish production system—a system that can actually compensate for routine group treatment with antibiotics through precautionary health and biosecurity? What aspects are behind the different antibiotic consumption patterns in the Italian setting? We argue that the Swedish ability to compensate for routine prophylactic antibiotic group treatment was the outcome of an extensive interaction process: ‘outsiders’ increased the general awareness of routine antibiotic use by debating it in the media, and ‘insiders’ took the debate seriously and consequently acted to develop a production system that was able to compensate for routine use of antibiotics. Based on both the Swedish and Italian experiences, we argue that a legal ban on routine group treatment does not in itself guarantee a change. Those who are supposed to adopt must first share the ideas the legislation rests on; second, they must be prepared to invest in a change of material structures; third, they must foresee a ‘fair’ distribution of costs and benefits among producers and users—that is, an economic context in which all players are incentivised to follow the same route.

Close